Barriers to Hepatitis C Treatment in HIV co-infected Patients in the Era of New Direct-Acting Antiviral Therapy

BACKGROUND: Hepatitis C virus (HCV) infection disproportionately affects HIV-infected patients. Co-infected patients have worse prognoses than mono-infected patients. HCV treatment with new oral direct acting antiviral (DAA) therapy is effective in HIV/HCV co-infected patients with cure rates simila...

Descripción completa

Detalles Bibliográficos
Autores principales: Deering, Caytlin, Coppock, Dagan, Boyle, Suzanne, Szep, Zsofia, Franks, Taneesa, Scott, Tiffany, Kesaris, Anna, Chou, Edgar, Lee, Dong Heun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631048/
http://dx.doi.org/10.1093/ofid/ofx163.1760

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631048/
http://dx.doi.org/10.1093/ofid/ofx163.1760

Ejemplares similares